Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.6 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |